⌘K

Login Start Free

Home/Filings/4/0000899243-22-004673

4//SEC Filing

Humer Kristian 4

Accession 0000899243-22-004673

CIK 0001590750other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:15 PM ET

Size

5.7 KB

Accession

0000899243-22-004673

Insider Transaction Report

Form 4

Period: 2022-02-02

Viridian Therapeutics, Inc.\DEVRDN

CFO and CBO

Transactions

Award
Stock Option (Right to Buy)
2022-02-02+90,000→ 90,000 total
Exercise: $18.51Exp: 2032-02-02→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1

filerCIK 0001872280

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 6:15 PM ET
Size: 5.7 KB

View on SEC.gov